Pierangelo Geppetti

Florence, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 156 publications

The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability.

The chronopharmacology of atogepant in migraine prevention: A real-world evaluation of influence of timing of administration on effectiveness and tolerability.

Journal: Cephalalgia : an international journal of headache

Published: March 25, 2026

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Levels of migraine controls following International Headache Society (IHS) recommendations with eptinezumab: Effectiveness and tolerability in a 24-week, prospective multicenter study (the TACHIS study).

Journal: Cephalalgia : an international journal of headache

Published: February 13, 2026

Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study).

Rapid effectiveness of eptinezumab to treat ongoing migraine attacks: preliminary data from an Italian multicenter real-world experience (the BE-FREE study).

Journal: Frontiers in neurology

Published: January 09, 2026

Sleep and anti-calcitonin gene related peptide (CGRP) drugs: current evidence and perspectives.

Sleep and anti-calcitonin gene related peptide (CGRP) drugs: current evidence and perspectives.

Journal: Sleep medicine reviews

Published: October 19, 2025

Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Fremanezumab in Children and Adolescents with Migraine.

Pharmacokinetics and Pharmacodynamics, Efficacy and Safety of Fremanezumab in Children and Adolescents with Migraine.

Journal: European journal of drug metabolism and pharmacokinetics

Published: October 03, 2025

Costs and use of antimigraine drugs in Italy: a ten-year analysis of national data.

Costs and use of antimigraine drugs in Italy: a ten-year analysis of national data.

Journal: The European journal of health economics : HEPAC : health economics in prevention and care

Published: September 20, 2025

The pharmacology of gepants in migraine: A scoping review on mechanisms, clinical applications, and combination strategies.

The pharmacology of gepants in migraine: A scoping review on mechanisms, clinical applications, and combination strategies.

Journal: Headache

Published: September 09, 2025

Evidence-based guidelines for the pharmacological treatment of migraine.

Evidence-based guidelines for the pharmacological treatment of migraine.

Journal: Cephalalgia : an international journal of headache

Published: April 25, 2025

Evidence-based guidelines for the pharmacological treatment of migraine, summary version.

Evidence-based guidelines for the pharmacological treatment of migraine, summary version.

Journal: Cephalalgia : an international journal of headache

Published: April 25, 2025

Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice.

Activation of peripheral NOP receptors reduces periorbital mechanical allodynia evoked by CGRP in mice.

Journal: British journal of pharmacology

Published: April 10, 2025

Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo.

Identification of isoxazole-based TRPA1 inhibitors with analgesic effects in vivo.

Journal: European journal of medicinal chemistry

Published: February 20, 2025

Advanced oxidation protein products activated TRPA1 in a neuropathic multiple sclerosis model.

Advanced oxidation protein products activated TRPA1 in a neuropathic multiple sclerosis model.

Journal: Brain : a journal of neurology

Published: January 16, 2025

Showing 1-12 of 156

Last Updated: 09/26/2026